Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
67 hedge funds and large institutions have $266M invested in Applied Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 17 reducing their positions, and 10 closing their positions.
65% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 17
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
5% more capital invested
Capital invested by funds: $252M → $266M (+$13.8M)
2% more funds holding
Funds holding: 66 → 67 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.52% less ownership
Funds ownership: 54.34% → 53.82% (-0.52%)
94% less call options, than puts
Call options by funds: $595K | Put options by funds: $9.26M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.75M |
| 2 |
O
OrbiMed
New York
|
+$4.69M |
| 3 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.43M |
| 4 |
Millennium Management
New York
|
+$1.05M |
| 5 |
Goldman Sachs
New York
|
+$952K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$7.41M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.33M |
| 3 |
KPW
Kore Private Wealth
New York
|
-$2.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.3M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.63M |
APLT Hedge Fund Activity: Q4 2020 in Review
67 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q4 2020, worth a combined $266M — up 5.5% from $252M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new APLT positions and 10 closed out — a net gain of 1 holder — while 28 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $4.75M. The largest seller was Rock Springs Capital Management, cutting an estimated $7.41M.
- 67 institutional investors held Applied Therapeutics (APLT) as of Q4 2020, up from 66 in Q3 2020.
- Funds reported $266M of Applied Therapeutics stock for Q4 2020, up 5.5% quarter-over-quarter.
- 11 funds opened new Applied Therapeutics positions in Q4 2020 and 10 closed out, a net change of +1 holder.
- The largest Applied Therapeutics buyer in Q4 2020 was BlackRock, an estimated $4.75M added.
- The largest Applied Therapeutics seller in Q4 2020 was Rock Springs Capital Management, an estimated $7.41M sold.
Based on aggregated 13F filings for Q4 2020.